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ABSTRACT
The mouse monoclonal and polyclonal antibodies were produced for the detection of intracellular pathogen
and potential warfare agent Francisella tularensis. Antibody titers obtained were 1:640 for polyclonal antibodies
and 1:320 for monoclonal antibodies. Both antibodies were used in the indirect enzyme-linked immunosorbent
assay (ELISA) found to detect F. tularensis whole cells. The limit of detection was 5.4×106 CFU/ml for polyclonal
antibodies and 6.9×106 CFU/ml for monoclonal antibodies. The value sample could  be distinguished from any
concentration of another gram-negative bacterium: Escherichia coli.
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1. INTRODUCTION
The potential biological warfare (BW) agent  Francisella
tularensis is a causative agent of tularemia in humans,
with several manifestations and different severity based
on the route of entry of  the pathogen. The last large-scale
epidemic of tularemia was observed in 1966-67 in Sweden1.
Due to low-infection dose, up to ten cells2 and natural
spreading through small rodents and mosquitoes combined
with simple cultivation, Center for Disease Control and
Prevention in Atlanta enrolled F. tularensis as the one of
the most risky BW agents it was enlisted into category
A between six most important BW agents. Importance of
F. tularensis as BW agents in comparison with others BW
agents was evaluated by a mathematical model3. The naturally
occurring tularemia infection exhibits the mortality4 rate
less than 3 per cent  for ulceroglandular form. The infection
is curable with chemotherapy using streptomycin5, gentamicin6
or fluoroquinolone derivates7.
The enzyme-linked immunosorbent assay (ELISA) has
been proved as a reliable technique for the diagnosis of
several serious diseases and detection of causative agents.
Sera from patient suffering with anthrax were evaluated
using ELISA8 method; the whole Bacillus anthracis cells
were detected using ELISA and compared with PCR and
flow cytometry9. Agglutination test and ELISA were used
for serological testing of sera from patients suffered from
brucellosis10 and antibodies against Brucella melitensis
were detected in sheep milk11. Murine serum from mice,
experimentally infected with Yersinia pestis, was evaluated
both for specific antibodies and antigens12, and plague
was diagnosed. Antibodies specific to outer lipopolysaccharide
(LPS) antigen O157 from Escherichia coli were detected
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by blocking ELISA13. Maltseva14 et al.  used ELISA for
serological screening for orthopoxviruses. ELISA is frequently
used for diagnosis of tularemic infection and also for direct
or indirect detection of F. tularensis. Evaluation of patients’
sera by ELISA was made by Carlsson15 et al.  for serotyping;
wherein LPS antigen from F. tularensis outer membrane
and polyclonal antibody labeled by horseradish peroxidase
were used. Antibodies against F. tularensis were examinated
in serum from wild boars16, and human sera from Norway,
Sweden and Kosovo17. The comparison of ELISA with
other immunological methods for patients’ sera has also
been reported18. Presence of F. tularensis cells was detected
by ELISA in tissue samples from European brown hares
and results were compared with immunochromatographic
handheld assay as also by PCR 19. Detection by biosensors
was also proposed as a  method for  the detection of BW
agents including F. tularensis20, and application of biosensors
allowed detection of whole F. tularensis cells21 as well as
serological diagnosis of tularemia22. Historical aspect of
F. tularensis as potential BW agent was also reviewed23.
As ELISA is a very routine method in middle-lend and
larger-lend laboratory facilities designated for defence and/
or epidemiologic purposes, our preserving effort is aimed
at optimisation of ELISA method parameters. Improving of
ELISA applicability in a manner for the use of antibodies
generated in the authors Laboratory was the aim of the
present study. One of the most important BW agent, F.
tularensis, was chosen as a model.
2. EXPERIMENTAL DETAILS
2.1 Preparation of Bacteria and Antigen
As model strain of F. tularensis LVS (ATCC 29684)
698
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was used. This strain expresses reduced virulence in humans
but remains fully virulent in rodent models of infection.
Bacteria were cultured on McLeod agar (Thayer-Martin
agar base, Merck Eurolab, Stockholm, Sweden; Bacto agar,
Oxoid, Basingstoke, United Kingdom) supplemented with
bovine hemoglobin (Bovine hemoglobin, BD, Franklin Lakes,
NJ USA) at 36.9°C and collected after 24 hour period.  Cells
were suspended in saline solution and bacterial content
was determined by re-cultivation. F. tularensis antigen was
prepared by 8 cycles of repeated freezing in liquid nitrogen
and thawing of bacterial suspension as published previously22,24-
25
. Finally antigen solution was adjusted to 0.15 mg/ml after
determining by Bradford Total Protein Kit (Sigma, St. Louis,
MO, USA). Another gram-negative bacterium Escherichia
coli (ATCC 9637) was used as negative control.
2.2 Preparation of Polyclonal Antibodies
The polyclonal antibodies specific to F. tularensis were
raised in 10 female BALB/c mice (BioTest, Konárovice, Czech
Rep.). Mice were subcutaneously inoculated with 102 CFU
of F. tularensis in 100 µl of saline solution and after 14 days
immunised s.c. with 106 CFU. On 21st day after first inoculation,
mice were boosted with 100 µl of antigen solution (prepared
as mentioned above) mixed with 100 µl of Freund´s complete
adjuvant (FCA) and on 28th day they were inoculated with
the same102 CFU of F. tularensis in saline solution, except
FCA was used. Non-immune (control) serum was obtained
from three donor mice, which were inoculated only with
saline solution at the same intervals as used for immunisation.
Blood was collected after 35 days by a cut of the ascellary
artery. Blood samples were clotted initially for 1 h at 4 °C
then again for 1 h at 37 °C, centrifuged first at 95 ×g for
5 min and finally at 375 ×g for 20 min.
2.3 Preparation of Monoclonal Antibodies
Monoclonal antibodies against F. tularensis were obtained
by hybridoma technology using live F. tularensis LVS cells.
The mouse spleen cells were obtained in the same immunisation
protocol as described in the case of polyclonal antibody
preparation and were fused with the mouse myeloma cell
line Sp2/0-Ag14. After cell fusion using PEG (Sigma, St
Louis, MO, USA), the selection in HAT medium (Sigma)
was performed. The selective pressure was maintained for
15 days, to guarantee the extinction of all the undesired
cells. After this period, all the cells were held in a medium
supplemented with HT medium (Sigma). Finally, this medium
was removed and the cultures were maintained in DMEM
(GIBCO BRL, Grand Island, NY, USA). Hybridomas were
expanded and further screened by ELISA using F. tularensis
antigen. The positive hybridomas were selected for limiting
dilution cloning and cryopreserved. From individual clones,
isotypes of antibodies were evaluated by mouse monoclonal
antibody isotyping kit (Roche, Indianapolis, IN, USA).
2.4 Solid-phase Extraction and Protein Amount
Determination
The total protein amount of poly- and monoclonal
antibodies was determined by Total Protein Kit (Sigma).
For determination of immunoglobulin fraction protein amount,
solid-phase extraction (SPE) on the column with CBindTM
L (Fluka, Buchs, Switzerland) was used according previously
used protocol26. Column was washed with 20 mM phosphate
buffer with 150 mM NaCl, pH 7.2. glycine buffer (100 mM
pH 2.2) was used for elution. The column was washed with
20 mM Tris/HCl pH 7.5 containing  6 M guanidine
hydrochloride. After purification, the amount of
immunoglobulins was determined by total protein kit.
2.5 Indirect Enzyme-linked Immunosorbent  Assay
A 96-well microplate (Gama, Ceské Budejovice, Czech
Rep.) was coated with 100 ml per well of bacterial cells (F.
tularensis or E. coli) suspended in saline solution for 2 h.
Afterwards, the plate was washed with saline solution and
blocked with 150 ml of gelatin (Merck, Whitehouse Station,
NJ, USA) for 1 h and washed. For blank purposes, only
three wells were coated  with gelatin. Into each well,
100 ml of 10-time diluted monoclonal or polyclonal antibodies
(in triplicate for each sample) was added and plates were
incubated at 37 °C for 60 min. After washing with saline
solution containing 0.2 per cent of Triton X-100, 100 µl
of 1:100 diluted antibodies with specificity against IgM
and labeled with HRP (Serotec, Oxford, UK) were added
per well. Plates were incubated at 37 °C for 30 min and
washed with saline solution containing 0.2 per cent Triton
X-100. Finally, 100 µl freshly prepared solution containing
0.5 mg/ml orthophenylendiamine (OPD) and 5 mM H2O2
was added in dark and allowed to react for 1 min. Reaction
was stopped with 100 ml of 2 M H2SO4. Optical density
was measured on ELISA reader MRX (Dynatech Laboratories,
Chantilly, VA, USA) with wavelength set to 490 nm.
Titers of monoclonal and polyclonal antibodies were
obtained in the same way by ELISA as described above.
Bacterial sample in this procedure was replaced by antigen
from F. tularensis prepared by freeze/thaw cycles. Titers
of either IgG or IgM were determined by secondary antibody
labeled with HRP (Serotec, Oxford, UK) and specific against
mouse IgG or IgM.
3. RESULTS AND DISCUSSION
3.1 Preparation of Antibody
Two types of antibodies were obtained: polyclonal
from mice suffering from tularemic infection combined with
consequent immunisation by antigen suspended into Freund´s
complete and incomplete adjuvant and monoclonal antibody
3E5B10G4. Monoclonal antibody was determined using
isotyping kit as class IgM isotype. Titers obtained by ELISA
and amount of protein in antibody solution for polyclonal
as well as monoclonal antibody and control (normal) mouse
sera are presented in Table 1. It was found that the highest
obtained titers were 1:640 for polyclonal antibody and 1:320
for monoclonal antibodies when assayed both for IgM fraction.
IgG fractions had minimal titers for both types of antibodies.
Amount of immunoglobulin was determined by total protein
kit after solid phase extraction and compared with total
700
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protein. Monoclonal antibody content was determined to
be 17.5 mg/ml and polyclonal antibody of 42.5 mg/ml while
the control mouse serum had 28.0 mg/ml.
In this study, no additional steps were used for  the
concentration or other pretreatment of antibodies in order
to reduce costs per analysis. Antibodies, hybridoma culture
supernants and mouse immune sera were used in a crude
state diluted ten times.
3.2 Indirect ELISA for the detection of F. tularensis
Dependence of optical density as ELISA output value
on concentration of  F. tularensis as analyte and E. coli
as negative control, has been expressed for polyclonal
antibody in Fig. 1. and for monoclonal one in Fig. 2.
Reached limit of detection (LOD) (LOD, S/N=3) was
5.4×106 CFU/ml for polyclonal antibody and 6.9 × 106 CFU/ml
for monoclonal one. Optical density obtained for F. tularensis
in amount equal to limit of detection was significantly
higher from the optical density obtained for E. coli adjusted
at any concentration.
If the ratio of optical densisty for signals obtained
from F. tularensis and E. coli samples is expressed for both
Figure 2. Indirect ELISA for monoclonal antibody. The whole
cells were loaded on the microplate. F. tularensis as
analyte and E. coli as negative control were used.
Output value optical density obtained from ELISA
reader was used. The error bars indicate estimated
SD (n = 3).
of antibodies (Fig. 3), one can see more sensitive signal
output for polyclonal antibody in comparison with quite
flat output for monoclonal antibody.
Although limit of detection evaluated as ~ 107 is quite
above the infection dose for F. tularensis; however, on
the other side, this limit of detection is quite sufficient
when employed after pre-enrichment step. With regard to
sensitivity, ELISA is not able to compete with such methods
like PCR. On the other side, ELISA is advantageous in the
way of number simultaneously analysed samples in combination
with low costs per unit analysis. If six wells were used
for negative and positive controls, it was possible to
contemporary detect as much as 90 samples in one contemporary
analysis on one standard microplate. ELISA is convenient
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Figure 1. Indirect ELISA for F. tularensis detection using
polyclonal antibody.  The whole cells were loaded on
the microplate and E. coli was used as negative control.
Output value optical density obtained from ELISA
reader was used. The error bars indicate estimated
SD (n = 3).
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Figure 3. Plot expressing polyclonal and monoclonal antibodies
sensitivity in indirect ELISA. In this figure, value
was obtained from the analyte (F. tularensis) signal
divided by signal received from E. coli for each
antibody. Data were taken from Fig. 1 and 2. The
error bars indicate estimated SD (n = 3).
 Polyclonal 
antibody 
Monoclonal 
antibody 
Control mouse 
serum 
Total protein (mg/ml) 85.7 35.7 75.4 
Globulins (mg/ml) 42.5 17.5 28.0 
Titer of IgM 1:640 1:320 1:10 
Titer of IgG 1:20 <1:10 1:10 
Table 1. Presentation of some basic characteristics of polyclonal
and monoclonal antibodies* and control serum obtained
from BALB/c mice
* Antibodies were specific against F. tularensis and titer was tested by
indirect ELISA. Titer under 1:10 is not significant. Globulin content
was determined by solid phase extraction and total protein kit.
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for characterisation of pre-cultivated microbes (including
F. tularensis) when combined with classical cultivation
tests. Therefore, cultivated cells were used throughout
this study to maintain standard test conditions.
One of the main tasks of this work was the comparison
of monoclonal and polyclonal antibodies applicability for
F. tularensis detection. The polyclonal antibody exposed
better analytical parameters. Current legislative in Czech
Republic and common legislative trends in the world make
experiments on animals more difficult, and therefore is simpler
to produce monoclonal antibodies from stocked hybridomas.
Costs of polyclonal antibody production are not marginally
higher than in the case of monoclonal one with regard to
all consumables and laboratory equipment needed. Nevertheless,
as monoclonal antibody preparation is more elaborative,
production of polyclonal antibody remains more readily
approachable.
Practical impact of ELISA method for defence purposes
is another task of this study. Since facilities for  ELISA
method are available in local and regional laboratories in
many countries including Czech Republic, it predominantly
acts as a tool for serological diagnosis in laboratory routine.
Any misuse of BW agent, including the one based on F. tularensis,
should be detectable in a number of  laboratories. For this,
reason could be ELISA simple approachable due to the presence
in clinical labs including the military ones. The present study
confirms the applicability of ELISA method for mass processing
of bacterial isolates. Even limit of detection (LOD) was
approximately on the similar level as in the case of performance
of biosensors for F. tularenis27 or E. coli 28. Though the
mobile laboratories and reconnaissance teams are typically
equipped with portable PCR (such as R.A.P.I.D. or Razor)
for its better sensitivity, established non-mobile laboratories
should use ELISA method for confirmation of isolates previous
or contemporary identification process. Performance of the
device was targetedly realised on F. tularensis. Accordingly,
Centre for Disease Control, Atlanta, enlisted  six most important
BW agents. One should notice that samples cultivation processes,
and ELISA performance were realised just in the same way
as one could process real samples.
4. CONCLUSIONS
Mouse polyclonal and monoclonal antibodies specific
against intracellular pathogen, and one of the most important
BW agent F. tularensis, were prepared, and consequently
the ELISA method for detection of F. tularensis was
developed. The limit of detection (LOD) was relatively high;
on the other side, the high number of contemporary measured
samples and low cost per unit analysis is pretty advantageous.
From the two tested antibodies, better presumptions to be
used in ELISA kit, construction proved the polyclonal one
over the monoclonal one.
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